Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Synbio Tech's Enterprise Value is NT$2,753 Mil.
Synbio Tech's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was NT$215 Mil. Therefore, Synbio Tech's EV-to-EBIT ratio for today is 12.80.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Synbio Tech's Enterprise Value is NT$2,753 Mil.
Synbio Tech's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was NT$294 Mil. Therefore, Synbio Tech's EV-to-EBITDA ratio for today is 9.35.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Synbio Tech's Enterprise Value is NT$2,753 Mil.
Synbio Tech's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was NT$1,039 Mil. Therefore, Synbio Tech's EV-to-Revenue ratio for today is 2.65.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Synbio Tech's Enterprise Value is NT$2,753 Mil.
Synbio Tech's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-562 Mil. Therefore, Synbio Tech's EV-to-FCF ratio for today is -4.90.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Synbio Tech (ROCO:1295) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Synbio Tech's current Enterprise Value is NT$2,753 Mil.
Synbio Tech's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$215 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Synbio Tech's current Enterprise Value is NT$2,753 Mil.
Synbio Tech's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$294 Mil.
Synbio Tech's current Enterprise Value is NT$2,753 Mil.
Synbio Tech's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,039 Mil.
Synbio Tech's current Enterprise Value is NT$2,753 Mil.
Synbio Tech's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$143 Mil.
Synbio Tech's current Enterprise Value is NT$2,753 Mil.
Synbio Tech's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-562 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synbio Tech Enterprise Value Related Terms
Synbio Tech Enterprise Value Historical Data
* Premium members only.
The historical data trend for Synbio Tech's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:1295 vs VRTX, REGN, ALNY: Enterprise Value Comparison
For the Biotechnology subindustry, Synbio Tech's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synbio Tech Enterprise Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Synbio Tech's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Synbio Tech's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Synbio Tech's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Enterprise Value of NT$2,753 Mil mean?
Synbio Tech (ROCO:1295) has a Enterprise Value of NT$2,753 Mil as of Jul. 17, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Synbio Tech and its competitors.
Is Synbio Tech's Enterprise Value too high?
Synbio Tech's current Enterprise Value is NT$2,753 Mil. Overall, Synbio Tech has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Synbio Tech's Enterprise Value compare to VRTX and REGN?
Synbio Tech's Enterprise Value of NT$2,753 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Biotechnology company?
A good Enterprise Value depends on the Biotechnology industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Synbio Tech and its competitors. Synbio Tech's current Enterprise Value is NT$2,753 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synbio Tech stock overvalued right now?
Synbio Tech (ROCO:1295) has a current Enterprise Value of NT$2,753 Mil. The current Enterprise Value is NT$2,753 Mil. Synbio Tech's overall GF Score™ is 44/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Synbio Tech (ROCO:1295), the current Enterprise Value is NT$2,753 Mil as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Synbio Tech Inc focus on functional research and manufacturing of probiotics for human health and economic animals. It has two reportable segments, Taiwan and Mainland China Segment to engage in the production and R&D technologies of the Taiwan Segment, including the production and sales of concentrated fermentation liquid, lactobacillus plantarum solid drinks, and lactobacillus plantarum granules for animal husbandry. It generates majority of revenue from Taiwan segment includes production and sale of lactobacillus plantarum powder, lactobacillus plantarum fermentation derivative products, probiotics dietary supplements, probiotics products for pets and economic animals, and probiotics products. It has presence in Taiwan, China, Southeast Asia, and Others.
44GF Score
Get the complete analysis for ROCO:1295
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:1295 has been successfully added to your 
